Teva Wins Largest Share Of AOK Tenders

BMI View: Teva will benefit from winning a large proportion of Germany's largest health insurance tenders wit the country keen to promote the use of generic drugs as it battles soaring drug spending. Therefore, while the sales of innovative drugs may experience a decline in Germany as a result of the patent cliff and the consequent rise in generic competition, we believe the high consumption of generic medicines by volume (75% in 2009) suggests opportunities for generic drugmakers in Europe's largest drug market.

To read the full article, please choose one of the following options: